| Name | Title | Contact Details |
|---|
Hendricks Regional Health is a non-profit, multi-specialty healthcare organization caring for communities in the Western and Central suburban area of Indianapolis since 1962, with a full-service hospital in Danville and medical buildings in Avon, Bainbridge, Brownsburg, Plainfield and Lizton. In December 2017, we will be opening our second hospital to serve the growing needs of the Brownsburg area.
Innovative Claims Strategies is a Iselin, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CareCentrix is a leader in managing care to the home. Headquartered in Hartford, Conn., CareCentrix connects patients with the care they need at home, through a national network of over 8,000 credentialed provider locations providers, with customer care centers located across the United States. CareCentrix provides optimal access to quality home care for more than 23 million lives by connecting providers with patients and helping them navigate the complex home care system. CareCentrix`s extensive range of services provides support and coordination for patients and their families in every step of the healing process, including home health, durable medical equipment (DME), home infusion, sleep management and care management services, which ultimately improve care transitions and reduce unnecessary readmissions and emergency room visits.
Electro-Optical Sciences is a Irvington, NY-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.